
Keywords: پروتئگلیکان سولفات کندرویتین; α; risk of type I error; β; risk of type II error; BBB; Basso-Beattie-Bresnahan; CI; confidence interval; CSPGs; chondroitin sulphate proteoglycans; D2; diversity; I2; inconsistency measure; IFNγ; interferon gamma; lacZ; betagalactosidase; M1; clas